solidarity trial treatments multinational phase iiiiv clinical trial organized world health organization partners compare four untested treatments hospitalized people severe trial announced march august patients countries recruited participate may announced international coalition simultaneously developing several candidate vaccines prevent disease calling effort solidarity trial treatments investigated remdesivir lopinavirritonavir combined lopinavirritonavir combined interferonbeta hydroxychloroquine chloroquine hydroxychloroquine chloroquine investigation discontinued june due concluding provided benefitcitation needed trial intends rapidly assess thousands infected people potential efficacy existing antiviral antiinflammatory agents yet evaluated specifically illness process called repurposing repositioning alreadyapproved drug different solidarity project designed give rapid insights key clinical enrolling people infection simplified gathering informed consent capturing data online clinical trial platform castor trial staff determine drugs available hospital platform randomizes hospitalized subject one trial drugs hospital standard care treating trial physician records submits followup information subject status treatment completing data input via castor edc design solidarity trial doubleblind normally standard highquality clinical trial needed speed quality trial across many hospitals global safety monitoring board physicians examine interim results assist decisions safety effectiveness trial drugs alter trial design recommend effective similar webbased study solidarity called discovery initiated march across seven countries inserm paris solidarity trial seeks implement coordination across hundreds hospital sites different countries including poorlydeveloped infrastructure clinical trials yet needs conducted rapidly according johnarne r√∏ttingen chief executive research council norway chairman solidarity trial international steering committee trial would considered effective therapies determined reduce proportion patients need ventilators say could huge impact national healthcare according director general aim trial dramatically cut time needed generate robust evidence drugs process using adaptive solidarity european discovery trials apply adaptive design rapidly alter trial parameters results four experimental therapeutic strategies adaptive designs within ongoing phase iiiiv clinical trials solidarity discovery projects may shorten trial duration use fewer subjects possibly expediting decisions early termination save costs interim results solidarity project shows early evidence success design changes across projects international locations made rapidly enhance overall outcomes affected people hasten use therapeutic individual combined drugs studied solidarity discovery projects already approved due safety concerns evidence heart arrhythmias leading higher death rates suspended hydroxychloroquine arm solidarity trial late may reinstated withdrew interim analysis june showed hydroxychloroquine provided benefit hospitalized people severely infected october world health organization solidarity trial produced interim report concluding remdesivir hydroxychloroquine lopinavir interferon regimens appeared little effect hospitalized indicated overall mortality initiation ventilation duration hospital gilead manufacturer remdesivir criticized solidarity trial methodology showed benefit treatments claiming international nature solidarity trial weakness whereas many experts regard multinational study purchase agreements eu gilead remdesivir granting emergency use authorization us fda october questioned solidarity trial scientists based positive clinical trial data interim analysis solidarity trial found remdesivir january canadian component solidarity trial reported inhospital people treated remdesivir lower death rates reduced need oxygen less mechanical ventilation less compared people receiving standardofcare march funding solidarity trial reached million individual donations charitable organizations governments countries involved financing trial july nearly patients countries approval recruit recruited participate trial countries regions expressed interest developed multinational coalition vaccine scientists defining global target product profile tpp identifying favorable attributes safe effective vaccines two broad categories vaccines longterm protection people higher risk healthcare workers vaccines provide rapidresponse immunity new international tpp team formed assess development promising candidate vaccines map candidate vaccines clinical trial worldwide publishing frequentlyupdated landscape vaccines rapidly evaluate screen promising candidate vaccines simultaneously tested humans design coordinate multiplesite international randomized controlled trial solidarity trial enable simultaneous evaluation benefits risks different vaccine candidates clinical trials countries high rates disease ensuring fast interpretation sharing results around vaccine coalition prioritize vaccines go phase ii iii clinical trials determine harmonized phase iii protocols vaccines achieving pivotal trial announced august roll next phase solidarity trial name solidarity plus trial countries trial enroll hospitalized patients test three new drugs potential treatment drugs include artesunate imatinib infliximab selection therapies done independent expert panel drugs already used indications artesunate used malaria imatinib cancers infliximab antitnf agent used crohns disease rheumatoid arthritis drugs donated purpose trial manufacturerscitation needed httpsenwikipediaorgwikisolidaritytrial